Daclatasvir, Asunaprevir Plus Ribavirin for HCV Genotype 1b Without NS5A RAV

NCT03004625 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: daclatasvir
DRUG: asunaprevir
DRUG: Ribavirin

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]